[Evidence-based medicine for treatment of aplastic anemia in children].
Kojima
Seiji
S
D000293:Adolescent; D000741:Anemia, Aplastic / Q000401:mortality / Q000628:therapy*; D001323:Autoantibodies / Q000627:therapeutic use; D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D006680:HLA Antigens; D018380:Hematopoietic Stem Cell Transplantation; D006648:Histocompatibility; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D015996:Survival Rate
D001323:Autoantibodies; D006680:HLA Antigens; D007166:Immunosuppressive Agents; C006606:anti-thyroglobulin; D016572:Cyclosporine; D003520:Cyclophosphamide